- Cambridge, MA
- Admin Support - Janet Mastrocola
- Avhana Health, Decibel Therapeutics, Gladius Pharmaceuticals, Thrasos Therapeutics, ZappRx
Dr. Eckstein comes to SR One from TVM Capital where he was a Venture Partner, Entrepreneur-in-Residence and appointed CEO and President of SelectX Pharmaceuticals. Prior to that, he was a General Partner in TVMs Boston life sciences practice where he focused on earlier-stage investments. He is currently Chairman of the Board of Directors of Thrasos Therapeutics, and a Director of Decibel Therapeutics, Gladius Pharmaceuticals and ZappaRx. He also was a member of the Board of Directors for Alios BioScience, CoNCERT Pharmaceuticals, Enanta Pharmaceuticals, SelectX Pharmaceuticals, Rapid Micro Biosystems, Anchor Therapeutics, and an Advisor to Sirtris Pharmaceuticals.
Jens was the founder of Akikoa Pharmaceuticals, a biotechnology start-up company focusing on hearing loss, and North Haven Systems, a life science IT company. Prior to joining TVM Capital, Jens led drug discovery programs at Enanta Pharmaceuticals, Inc. and Mitotix, Inc.
He is the author of multiple scientific publications and holds several issued and pending patents. Jens is an Advisor to the Alzheimer Research Forum (ARF), a Board Member of BioHealth Innovation (BHI) and a Kauffman Fellow.
Jens is the father of three teenagers and lives with his family in Cambridge, Massachusetts.